Technical Analysis for BVNRY - Bavarian Nordic

Grade Last Price % Change Price Change
grade D 8.6 -16.10% -1.6500
BVNRY closed down 16.1 percent on Thursday, June 18, 2020, on 39 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BVNRY trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Multiple of Ten Bearish Other 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 200 DMA Bullish -16.10%
Calm After Storm Range Contraction -16.10%
Narrow Range Bar Range Contraction -16.10%
Older signals for BVNRY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Bavarian Nordic A/S, a biotechnology company, develops, manufactures, and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer. The company markets non-replicating smallpox vaccine under the IMVAMUN and IMVANE names. It is also developing MVA-BN Filo that is in Phase III trial for the treatment of Ebola and Marburg; MVA-BN RSV, which is in Phase II clinical development stage for the prevention of respiratory syncytial virus; and MVA-BN HPV that is in preclinical development stage to treat human papillomavirus. In addition, the company is developing PROSTVAC, which is in Phase III clinical development for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer; CV301 that is in Phase II clinical trial for the treatment multiple cancers; and MVA-BN Brachyury that has completed Phase I clinical trial for the treatment of metastatic cancer. The company has collaboration agreements with National Cancer Institute; Bristol-Myers Squibb; Janssen Pharmaceuticals, Inc.; Biomedical Advanced Research and Development Authority; US Department of Defense; and PCI Biotech. The company operates in the United States, Holland, Canada, and internationally. Bavarian Nordic A/S was founded in 1994 and is headquartered in Kvistgård, Denmark.
Biotechnology Cancer Clinical Medicine Drugs Life Sciences Infectious Diseases Vaccines Bristol Myers Squibb Cancer Vaccines Hpv Bavarian Nordic Ebola Metastatic Cancer Ebola Vaccine National Cancer Institute Biomedical Advanced Research And Development Authority Company Markets Non Replicating Smallpox Cv301 Minimally Symptomatic Metastatic Castration Resistant Prostate Cancer Prostvac Treatment Multiple Cancers Treatment Of Life Threatening Infectious Diseases Treatment Of Metastatic Cancer Us Department Of Defense

Is BVNRY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 22.7
52 Week Low 5.04
Average Volume 515
200-Day Moving Average 9.7430
50-Day Moving Average 8.7405
20-Day Moving Average 8.1813
10-Day Moving Average 9.8070
Average True Range 0.7308
ADX 19.72
+DI 43.6223
-DI 47.5082
Chandelier Exit (Long, 3 ATRs ) 8.2576
Chandelier Exit (Short, 3 ATRs ) 7.2324
Upper Bollinger Band 11.8751
Lower Bollinger Band 4.4875
Percent B (%b) 0.56
BandWidth 90.2986
MACD Line 0.3494
MACD Signal Line 0.2326
MACD Histogram 0.1168
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.1500
Resistance 3 (R3) 11.4333 10.8667 10.7250
Resistance 2 (R2) 10.8667 10.2173 10.7250 10.5832
Resistance 1 (R1) 9.7333 9.8161 9.4500 9.4500 10.4416
Pivot Point 9.1667 9.1667 9.0250 9.0250 9.1667
Support 1 (S1) 8.0333 8.5173 7.7500 7.7500 6.7584
Support 2 (S2) 7.4667 8.1161 7.3250 6.6168
Support 3 (S3) 6.3333 7.4667 6.4750
Support 4 (S4) 6.0500